Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert M Guthrie

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
The Journal of Family Practice|February 5, 2016
The use of dual antiplatelet therapy in high-risk patients with acute coronary syndromesRobert M Guthrie
Postgraduate Medicine|May 10, 2015
Clinical use of dipeptidyl peptidase-4 and sodium-glucose cotransporter 2 inhibitors in combination therapy for type 2 diabetes mellitusRobert M Guthrie
Cardiology|December 17, 2010
Where does the evidence lead us for the proper use of angiotensin II inhibitors in the management of cardiovascular disease?Robert M Guthrie
Postgraduate Medicine|March 6, 2010
Use of rosuvastatin in preventing vascular events in patients with elevated C-reactive protein. CommentaryRobert M Guthrie
Postgraduate Medicine|August 12, 2009
Reshaping the dyslipidemia management paradigmRobert M Guthrie
Postgraduate Medicine|February 9, 2013
Use of home-based subcutaneous immunoglobulin therapy in elderly patients with primary immunodeficiency diseasesRobert M Guthrie
Hospital Practice (1995)|March 8, 2013
Review of diuretic and ultrafiltration strategies in patients with acute decompensated heart failureRobert M Guthrie
Postgraduate Medicine|June 11, 2013
Sodium-glucose co-transporter 2 inhibitors and the potential for cardiovascular risk reduction in patients with type 2 diabetes mellitusRobert M Guthrie
Expert Opinion on Drug Safety|September 20, 2007
The safety of rosuvastatin: effects on renal and hepatic functionRobert M Guthrie, Daniel R Martin
Journal of Clinical Hypertension (Greenwich, Conn.)|June 5, 2013
Telmisartan/Hydrochlorothiazide combination therapy for the treatment of hypertension: a pooled analysis in older and younger patientsSverre E Kjeldsen, Helmut Schumacher, Steen Neldam, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
The Journal of Family Practice|February 5, 2016
The use of dual antiplatelet therapy in high-risk patients with acute coronary syndromesRobert M Guthrie
Postgraduate Medicine|May 10, 2015
Clinical use of dipeptidyl peptidase-4 and sodium-glucose cotransporter 2 inhibitors in combination therapy for type 2 diabetes mellitusRobert M Guthrie
Cardiology|December 17, 2010
Where does the evidence lead us for the proper use of angiotensin II inhibitors in the management of cardiovascular disease?Robert M Guthrie
Postgraduate Medicine|March 6, 2010
Use of rosuvastatin in preventing vascular events in patients with elevated C-reactive protein. CommentaryRobert M Guthrie
Postgraduate Medicine|August 12, 2009
Reshaping the dyslipidemia management paradigmRobert M Guthrie
Postgraduate Medicine|February 9, 2013
Use of home-based subcutaneous immunoglobulin therapy in elderly patients with primary immunodeficiency diseasesRobert M Guthrie
Hospital Practice (1995)|March 8, 2013
Review of diuretic and ultrafiltration strategies in patients with acute decompensated heart failureRobert M Guthrie
Postgraduate Medicine|June 11, 2013
Sodium-glucose co-transporter 2 inhibitors and the potential for cardiovascular risk reduction in patients with type 2 diabetes mellitusRobert M Guthrie
Expert Opinion on Drug Safety|September 20, 2007
The safety of rosuvastatin: effects on renal and hepatic functionRobert M Guthrie, Daniel R Martin
Journal of Clinical Hypertension (Greenwich, Conn.)|June 5, 2013
Telmisartan/Hydrochlorothiazide combination therapy for the treatment of hypertension: a pooled analysis in older and younger patientsSverre E Kjeldsen, Helmut Schumacher, Steen Neldam, et al.
Pageof 3